Document is current

Article History

Accepted: 12 August 2022

First Online: 22 September 2022

Declarations

:

: Ajay Dhakal has received institutional funding from Celcuity Inc. and Puma biotechnology for research. Ajay Dhakal has received consulting fees from Gilead and MJH life sciences. Amanda E. D. Van Swearingen has nothing to disclose. Ruth O'Regan reports grants and personal fees from Novartis, personal fees from Pfizer, personal fees from Genomic Health, personal fees from Biotheranostics, personal fees from Lilly, personal fees from PUMA, personal fees from Genentech, personal fees from Immunomedics, and personal fees from Macrogenics, outside the submitted work. Carey K. Anders reports research funding from PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics, ZION, Novartis, and Pfizer. Carey K. Anders has received consulting fees from Genentech, Eisai, IPSEN, Seattle Genetics; Astra Zeneca, Novartis, Immunomedics, Elucida, and Athenex. Carey K. Anders has received royalties from UpToDate and Jones and Bartlett outside the submitted work.

: This article does not contain any studies with human or animal subjects performed by any of the authors.